Pfizer’s Bourla: State of US Presidential Transition Not ‘Ideal’ For Vaccine Rollout

Pfizer and BioNTech have accumulated enough safety data to submit an emergency use authorization, and Pfizer CEO Bourla says at the Stat Summit that he is ‘comfortable’ US distribution of the vaccine will go well despite the unusually complicated government transition.